| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0096 | 0.9 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |